Astera Labs (NASDAQ:ALAB) Updates Q2 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) updated its second quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.680-0.700 for the period, compared to the consensus earnings per share estimate of 0.500. The company issued revenue guidance of $355.0 million-$365.0 million, compared to the consensus revenue estimate of $310.0 million.

Astera Labs Stock Up 7.2%

NASDAQ:ALAB traded up $14.44 during mid-day trading on Tuesday, hitting $215.69. 7,471,497 shares of the stock traded hands, compared to its average volume of 5,317,249. The stock has a market capitalization of $36.94 billion, a price-to-earnings ratio of 176.80, a PEG ratio of 3.99 and a beta of 3.34. Astera Labs has a 52 week low of $63.40 and a 52 week high of $262.90. The firm’s 50 day moving average is $139.00 and its two-hundred day moving average is $153.00.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts predict that Astera Labs will post 1.48 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ALAB shares. UBS Group started coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Stifel Nicolaus set a $236.00 price target on shares of Astera Labs in a research report on Friday. Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $250.00 price target on shares of Astera Labs in a report on Tuesday, April 21st. Finally, Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target for the company. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average price target of $199.20.

Insider Activity

In related news, CEO Jitendra Mohan sold 10,188 shares of the firm’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the sale, the chief executive officer owned 4,069,134 shares in the company, valued at approximately $713,929,560.30. This trade represents a 0.25% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the transaction, the general counsel directly owned 118,084 shares in the company, valued at approximately $12,725,912.68. The trade was a 7.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,064,888 shares of company stock worth $150,764,723 in the last ninety days. Corporate insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. State Street Corp raised its stake in shares of Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares during the period. Morgan Stanley boosted its holdings in shares of Astera Labs by 33.0% in the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after buying an additional 480,009 shares in the last quarter. Amundi boosted its holdings in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC raised its position in Astera Labs by 9.0% in the 4th quarter. Rafferty Asset Management LLC now owns 1,166,716 shares of the company’s stock valued at $194,095,000 after purchasing an additional 96,241 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in Astera Labs by 162.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,164,414 shares of the company’s stock valued at $193,713,000 after purchasing an additional 720,844 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.